EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Differential expression and clinical significance of IGF2BP3 in peritoneal dialysate of patients with varying duration of peritoneal dialysis

Xiaoqi Shao iD, Ling Yao iD, Jiao Fu iD, Mengmeng He iD, Pei Zhang iD

Clinical and Translational Science · 2024

DOI: 10.1111/cts.13774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Xiaoqi Shao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Peritoneal Dialysis. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to investigate the differential expression of insulin‐like growth factor 2 mRNA‐binding protein 3 (IGF2BP3) in the peritoneal dialysate among patients with different durations of peritoneal dialysis and its association with the angiogenic marker vascular* endothelial growth factor (VEGF), the fibronectin (FN), and various clinical indicators. A cohort of 122 peritoneal dialysis patients was categorized into short‐term (≤1 year, n = 33), mid‐term (>1 and ≤5 years, n = 55), and long‐term (>5 years, n = 34) groups based on dialysis duration. We utilized enzyme‐linked immunosorbent assay (ELISA) and western blot assays to quantify the levels of IGF2BP3, VEGF, and FN in the dialysate. Our findings showed a progressive increase in IGF2BP3 levels with the duration of PD, with the long‐term group exhibiting significantly higher levels than both the short‐term and mid‐term groups ( p < 0.001). A positive correlation between IGF2BP3 and VEGF ( r = 0.386, p = 0.013), as well as between IGF2BP3 and FN ( r = 0.340, p = 0.030), was observed. IGF2BP3 levels also correlated positively with serum creatinine, calcium, and phosphorus levels. In vitro analysis further confirmed that IGF2BP3 expression is enhanced in human peritoneal mesothelial cells under high‐glucose conditions ( p < 0.05). The study highlights the potential of IGF2BP3 in PD effluent as a biomarker for monitoring PF progression, with its expression significantly correlated with the duration of PD (Pearson r = 0.897, p < 0.001). In conclusion, our results underscore a correlation between elevated IGF2BP3 levels and PD duration, suggesting the clinical significance of IGF2BP3 as a biomarker for PF progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor APeritoneal DialysisHumansPeritoneumClinical RelevanceDialysis SolutionsBiomarkers

Substanzen

Vascular Endothelial Growth Factor ADialysis SolutionsBiomarkers

Autor:innen und Institutionen

  • Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

ORCID-Profile: Xiaoqi Shao, Ling Yao, Jiao Fu, Mengmeng He, Pei Zhang

Zitieren

APA

Shao, X., Yao, L., Fu, J., He, M., & Zhang, P. (2024). Differential expression and clinical significance of IGF2BP3 in peritoneal dialysate of patients with varying duration of peritoneal dialysis. Clinical and Translational Science. https://doi.org/10.1111/cts.13774

Vancouver

Shao X, Yao L, Fu J, He M, Zhang P. Differential expression and clinical significance of IGF2BP3 in peritoneal dialysate of patients with varying duration of peritoneal dialysis. Clinical and Translational Science. 2024. doi:10.1111/cts.13774

BibTeX
@article{Shao2024,
  author = {Shao, Xiaoqi and Yao, Ling and Fu, Jiao and He, Mengmeng and Zhang, Pei},
  title = {Differential expression and clinical significance of IGF2BP3 in peritoneal dialysate of patients with varying duration of peritoneal dialysis},
  journal = {Clinical and Translational Science},
  year = {2024},
  doi = {10.1111/cts.13774}
}
Kostenlos starten →